The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Open accessAbstract
Devic's disease [neuromyelitis optica (NMO)] is an idiopathic inflammatory demyelinating disease of the CNS, characterized by attacks of optic neuritis and myelitis. The mechanisms that result in selective localization of inflammatory demyelinating lesions to the optic nerves and spinal cord are unknown. Serological and clinical evidence of B cell autoimmunity has been observed in a high proportion of patients with NMO. The purpose of this study was to investigate the importance of humoral mechanisms, including complement activation, in producing the necrotizing demyelination seen in the spinal cord and optic nerves. Eighty-two lesions were examined from nine autopsy cases of clinically confirmed Devic's disease. Demyelinating activity in the lesions was immunocytochemically classified as early active (21 lesions), late active (18 lesions), inactive (35 lesions) or remyelinating (eight lesions) by examining the antigenic profile of myelin degradation products within macrophages. The pathology of the lesions was analysed using a broad spectrum of immunological and neurobiological markers, and lesions were defined on the basis of myelin protein loss, the geography and extension of plaques, the patterns of oligodendrocyte destruction and the immunopathological evidence of complement activation. The pathology was identical in all nine patients. Extensive demyelination was present across multiple spinal cord levels, associated with cavitation, necrosis and acute axonal pathology (spheroids), in both grey and white matter. There was a pronounced loss of oligodendrocytes within the lesions. The inflammatory infiltrates in active lesions were characterized by extensive macrophage infiltration associated with large numbers of perivascular granulocytes and eosinophils and rare CD3(+) and CD8(+) T cells. There was a pronounced perivascular deposition of immunoglobulins (mainly IgM) and complement C9neo antigen in active lesions associated with prominent vascular fibrosis and hyalinization in both active and inactive lesions. The extent of complement activation, eosinophilic infiltration and vascular fibrosis observed in the Devic NMO cases is more prominent compared with that in prototypic multiple sclerosis, and supports a role for humoral immunity in the pathogenesis of NMO. Based on this study, future therapeutic strategies designed to limit the deleterious effects of complement activation, eosinophil degranulation and neutrophil/macrophage/microglial activation are worthy of further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,542
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
(1964) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,409
Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Self-citationWeinshenker, B. G., O'Brien, P. C., Petterson, T. M., Noseworthy, J. H., Lucchinetti, C. F., Dodick, D. W., Pineda, A. A., Stevens, L. N., & Rodriguez, M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6<878::aid-ana10>3.0.co;2-q · Cited by 894
Self-citationGold, R., Schmied, M. C., Giegerich, G., Breitschopf, H., Hartung, H., Toyka, K. V., & Lassmann, H. (1994) · PubMed · Cited by 675
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612
Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
Daugherty, B. L., Siciliano, S. J., DeMartino, J. A., Malkowitz, L., Sirotina, A., & Springer, M. S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2349 · Cited by 547
Monocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 530
Storch, M. K., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 522
Filley, W. V., Kephart, G. M., Holley, K. E., & Gleich, G. J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91152-7 · Cited by 521
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., & Lassmann, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430409 · Cited by 422
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.
O'Riordan, J. I., Gallagher, H. L., Thompson, A. J., Howard, R. S., Kingsley, D. P., Thompson, E. J., McDonald, W. I., & Miller, D. H. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.4.382 · Cited by 397
Mandler, R. N., Ahmed, W., & Dencoff, J. E. (1998) · Neurology · doi:10.1212/wnl.51.4.1219 · Cited by 366
Regulation of Antibody Responses via Antibodies, Complement, and Fc Receptors
Heyman, B. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.709 · Cited by 353
Devic's neuromyelitis optica: A clinicopathological study of 8 patients
Mandler, R. N., Davis, L. E., Jeffery, D. R., & Kornfeld, M. (1993) · Annals of Neurology · doi:10.1002/ana.410340211 · Cited by 335
Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296
Vass, K., & Lassmann, H. (1990) · Europe PMC (PubMed Central) · Cited by 238
Breitschopf, H., Suchanek, G., Gould, R., Colman, D., & Lassmann, H. (1992) · Acta Neuropathologica · doi:10.1007/bf00227734 · Cited by 235
Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases.
Hart, M. N., & Earle, K. M. (1975) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.38.6.585 · Cited by 182
Rothenberg, M. E., Ownbey, R. T., Mehlhop, P. D., Loiselle, P. M., van de Rijn, M., Bonventre, J. V., Oettgen, H. C., Leder, P., & Luster, A. D. (1996) · PubMed Central · Cited by 180
Physiology and Pathophysiology of Complement: Progress and Trends
Morgan, B. P., & McGeer, P. L. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084686 · Cited by 127
Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.
Kernen, P., Wymann, M. P., von Tscharner, V., Deranleau, D. A., Tai, P. C., Spry, C. J. F., Dahinden, C. A., & Baggiolini, M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115230 · Cited by 111
Aboriginals with multiple sclerosis
Mirsattari, S. M., Johnston, J. B., McKenna, R. M., Bigio, M. R. D., Orr, P., Ross, R. T., & Power, C. (2001) · Neurology · doi:10.1212/wnl.56.3.317 · Cited by 107
Activated Eosinophils Are the Major Source of Th2-Associated Cytokines in the Schistosome Granuloma
Rumbley, C. A., Sugaya, H., Zekavat, S. A., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.1003 · Cited by 95
Mandler, R. N., Dencoff, J. D., Midani, F., Ford, C. C., Ahmed, W., & Rosenberg, G. A. (2001) · Brain · doi:10.1093/brain/124.3.493 · Cited by 77
Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus
Bonnet, F., Mercié, P., Morlat, P., Hocké, C., Vergnes, C., Ellie, E., Viallard, J., Faure, I., Pellegrin, J., Beylot, J., et al. (1999) · Lupus · doi:10.1191/096120399678847696 · Cited by 76
Devic's Syndrome and Systemic Lupus Erythematosus: A Case Report With Necropsy
Kinney, E. L. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500460077012 · Cited by 68
Eosinophilic vasculitis in connective tissue disease
Chen, K.-R., Su, W. P. D., Pittelkow, M. R., Conn, D. L., George, T. J., & Leiferman, K. M. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90318-7 · Cited by 66
Butter, C., Baker, D., O'Neill, J. K., & Turk, J. L. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90209-p · Cited by 64
Haase, C. G., & Schmidt, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01949-8 · Cited by 50
Venge, P. (1995) · Respiratory Medicine · doi:10.1016/0954-6111(95)90062-4 · Cited by 38
TRANSVERSE MYELITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: TWO CASES WITH MAGNETIC RESONANCE IMAGING
Simeón‐Aznar, C. P., Tolosa-Vilella, C., CUENCA-LUQUE, R., Jordana-Comajuncosa, R., Ordi‐Ros, J., & Bosch, J. (1992) · Rheumatology · doi:10.1093/rheumatology/31.8.555 · Cited by 24
Complement as a promiscuous signal transduction device.
Asghar, S. S., & Pasch, M. C. (1998) · PubMed · Cited by 17
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Self-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
Self-citationDevelopment, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
“We speculate that endothelial leakage accompanying inflammatory events initiated by the binding of NMO-IgG to the extracellular face of AQP4 accounts for the abundance of IgM in immune complexes deposited around penetrating vessels in lesions of autopsied spinal cord from patients who had NMO (2).”
Background
Metadata
- Authors
- Lucchinetti, C. F.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-07-01
- Volume
- 125
- Issue
- 7
- Pages
- 1450-1461
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2161681716
- Cited by
- 1,210
- References
- 36
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.